John Oyler | $1B+

Get in touch with John Oyler | John Oyler, cofounder and chairman of BeiGene, is one of the most prominent figures in global oncology drug development, helping build a multinational biopharmaceutical company centered on innovative, accessible cancer therapies. After successful ventures in medical technology and data analytics, he launched BeiGene in 2010 with a mission to integrate world-class research with large-scale clinical operations across Asia, Europe, and the United States. Under his leadership, the company has developed breakthrough cancer drugs, secured major partnerships with industry leaders like Novartis and Amgen, and scaled into a global enterprise listed on multiple exchanges. Known for his scientist–entrepreneur mindset, Oyler has reshaped how biotech innovation and commercialization connect across continents.

​John V. Oyler (born 1968) is an American executive.[1] He is known for co-founding BeOne, a biotechnology company, with biochemist Xiaodong Wang.[2] Early life and education Oyler grew up in Pittsburgh, Pennsylvania. He attended the Massachusetts Institute of Technology.[3] He graduated with a degree in mechanical engineering in 1990.[2][4] Career Oyler began his career as a consultant at McKinsey & Company, which often involved traveled to China.[5] During his time at McKinsey, he earned an MBA degree from Stanford University and continued to work there after graduate school.[2] Oyler joined Genta, a biotechnology company focused on cancer drugs, in 1997. At Genta, Oyler hired new management and grew the company's valuation from a few million dollars to $1.7 billion. In 1998, Oyler was a founder of Telephia, a telecom research company where he served as president.[6][5][7] Nielsen Holdings acquired Telephia in 2007.[8] Oyler was also headed Galenea, a company focused on treatments for psychiatric diseases,[9] from 2002 to 2004.[10] In 2005, Oyler returned to China[5] and co-founded BioDuro, a contract research organization.[9] PPD acquired BioDuro in 2009.[11] BeOne Main article: BeiGene Oyler co-founded BeOne in 2010 with Chinese biochemist Xiaodong Wang, whom Oyler met while working at BioDuro.[2] BeOne has developed two cancer medicines, namely Tevimbra, a checkpoint inhibitor, and Brukinsa, a Bruton's tyrosine kinase inhibitor.[3] As of 2025, BeOne has 11,000 employees.[12] Personal life Oyler is married and has one daughter. See also BeiGene Xiaodong Wang (biochemist)

Disclaimer: This profile is based on publicly available information. No endorsement or affiliation is implied.

---

Join UHNWI direct Affiliate Program

Earn Passive Income by Sharing Verified Contact Information of Billionaires, Centi-Millionaires, and Multi-Millionaires on the UHNWI Direct Platform

Maximize your earnings potential by sharing direct and validated contact information of the ultra-wealthy, including billionaires, centi-millionaires, and multi-millionaires. Join the UHNWI Direct platform and tap into a lucrative passive income stream by providing valuable data to those seeking high-net-worth connections. Start earning today with UHNWI Direct.

You may also be interested in reviewing other UHNWIs profiles.

To find the person you want to contact, start typing their name or other relevant tags in the search bar.

Please note: Our database contains over 10,000 direct contacts of UHNWIs, and it is highly likely that the individual you are seeking is already included. However, creating individual profiles for each contact is a meticulous and time-intensive process, So, if you are unable to find the profile of the individual you are looking for, please click here.

Filter by Net Worth: All | Billionaires | Centi-Millionaires | Multi-Millionaires

Filter by Location: All | USA | Canada | Europe | UK | Russia & CIS | Asia | MEIA | Australia | Latin America

Filter by Age: 1920-1930 | 1930-1940 | 1940-1950 | 1950-1960 | 1960-1970 | 1970-1980 | 1980-1990 | 1990-2000

Filter by: Men | Women

Related People

---

Support our Research

UHNWI data is an independent wealth intelligence initiative led by a team of data researchers dedicated to building the world’s most comprehensive archive of individuals with a net worth exceeding $100 million. We believe in open access to structured knowledge — freely available, meticulously curated, and ethically maintained. This work is complex, time-intensive, and demands significant resources. If you find value in what we do, we invite you to support our mission with a donation. Your contribution helps preserve the independence, depth, and lasting impact of this unique research project.

$5.00

$10.00

$20.00

$30.00

$50.00

$100.00

Custom Amount

Please enter an amount

$

One-Time Donation Weekly Donation Monthly Donation Quarterly Donation Annual Donation

Support us by covering the fees we have to pay

3% Cover the Fee

Support our Research Support our Research

Marketing Tools

Essential marketing tools to effectively engage wealthy individuals, tailored to meet any personal, marketing, or sales objectives.

Use tags below for more precise targeting.